Ultra-Rare Disease Testing Jumps

Amplity Medical

Patient Engagement Rare Disease

Ultra-Rare Disease Testing Up 156%

Download PDF

Clinical nurse educators (CNEs) find people living with disease, provide education, and encourage family variant testing.

OUR TASK

CNEs educate eligible patients on screening for an ultra-rare disease. Over five months, Amplity’s CNEs engaged 384 people living with disease; nearly half of those individuals got a test and 24% tested positive. Although biotech companies often rely on testing companies to communicate with patients, when CNEs get involved, testing jumps dramatically.

Download PDF

The Ask

CLIENT

Global

Mid-Sized BioPharma

Educate Patients + HCPs

Make sure HCPs and people who display symptoms know about this ultra-rare disease.

Encourage Family Variant Testing

Encourage diagnosed patients’ family members to get tested for the genetic mutation associated with the disease.

The Approach

TOOLS

Field Team

Remote Engagement

Deploy Clinical Nurse Educators

Equipped with skills and scientific credentials, nurse educators open doors in ways that sales teams cannot.

Educate Patients

Help patients living with disease understand the course of the disease, therapeutic options, and the importance of staying on therapy.

Encourage Testing

Because the condition is autosomal dominant, encourage patients’ family members to test.

The Results

OUTCOME

Business Objectives Exceeded

Rare Patients Identified

Client Satisfaction

350+ Patients Engaged In 5 Months

In the first five months of the program, 384 people living with symptoms agreed to have conversations with an Amplity clinical nurse; of those, 47% received a genetic test. Of those tested, 27% had the disease variant.

95% Of Patients Complete Family Mapping

Family mapping is a critical first step to finding additional patients with an autosomal genetic disease. After speaking with Amplity CNEs, 95% of identified people living with the disease had completed family mapping, helping the client understand who has and has not been tested.

Number Of Family Tests More Than Doubles

CNEs do a far better job than testing companies in talking to patients about family variant testing. From quarter to quarter, the number of family variant tests increased 156%.